Natco Pharma board revises the remuneration of chairman

29 May 2012 Evaluate
Natco Pharma has informed that the Board of Directors of the Company at its meeting held on May 28, 2012,has transacted the recommendations of the Remuneration Committee of the Board of Directors, the Board, subject to the approval of members at the ensuing General Meeting, had revised the remuneration payable to V. C. Nannapaneni, Chairman and Managing Director of the Company and redesignated Rajeev Nannapaneni as Vice Chairman & CEO besides increasing his remuneration with effect from  June 01, 2012 for a period of three years.
 
The above information is part of company’s filing submitted to the BSE.



Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×